On April 30, 2025, ABVC Biopharma, Inc. sold 724,372 shares of common stock for over $436,000 to 15 non-U.S. investors and later issued 306,041 additional shares for approximately $183,625 to 7 more non-U.S. investors; voting rights were transferred to the company's chairman. This filing was made on May 14, 2025, as a formal report of the transactions.